Medicare Enrolled

Dr. David Waterhouse, MD

Hematology & Oncology · Cincinnati, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
3301 MERCY HEALTH BLVD STE 100, Cincinnati, OH 45211
5137512145
In practice since 2005 (20 years)
NPI: 1578557864 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Waterhouse from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Waterhouse? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Waterhouse

Dr. David Waterhouse is a hematology & oncology specialist in Cincinnati, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Waterhouse performed 1,146 Medicare services across 475 unique beneficiaries.

Between the years covered by Open Payments, Dr. Waterhouse received a total of $1,054,656 from 45 pharmaceutical and/or device companies across 976 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Waterhouse is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 27% volume in OH $1,054,656 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,146
Medicare services
Top 27% in OH for hematology & oncology
475
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~57 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid)
An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram.
374 $0 $1
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
149 $81 $348
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
116 $8 $35
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
90 $93 $343
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
70 $10 $62
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
56 $54 $230
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
54 $94 $673
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
45 $11 $93
Additional sequential IV infusion, 1 hour or less
This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less.
39 $21 $152
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
35 $63 $268
New patient office visit, complex (60-74 min) 26 $152 $644
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
26 $118 $540
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
26 $139 $732
Intravenous injection of additional new drug or substance
Administration of an additional new medication or substance directly into a vein.
21 $11 $105
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
19 $47 $304
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
9.8% high complexity
38.4% medium
51.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,054,656
Total received (2018-2024)
Avg $150,665/year across 7 years
Top 1% in OH for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
976
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$805,221 (76.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$218,785 (20.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$30,649 (2.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$205,537
2023
$259,387
2022
$210,495
2021
$153,208
2020
$103,842
2019
$82,404
2018
$39,782

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$70,627
Amgen Inc.
$56,179
Merck Sharp & Dohme LLC
$30,160
E.R. Squibb & Sons, L.L.C.
$24,941
AstraZeneca Pharmaceuticals LP
$11,225
Janssen Scientific Affairs, LLC
$2,477
ABBVIE INC.
$2,469
PFIZER INC.
$1,588
Aveo Pharmaceuticals, Inc.
$1,480
Bayer Healthcare Pharmaceuticals Inc.
$1,428
Daiichi Sankyo Inc.
$1,311
Ethicon Inc.
$938
Astellas Pharma US Inc
$136
BIOPROTECT MEDICAL, INC.
$117
JAZZ PHARMACEUTICALS INC.
$66
Cumberland Pharmaceuticals, Inc.
$64
PROGENICS PHARMACEUTICALS, INC.
$63
Takeda Pharmaceuticals U.S.A., Inc.
$50
Novartis Pharmaceuticals Corporation
$46
Lilly USA, LLC
$36
Fresenius Kabi USA, LLC
$34
Gilead Sciences, Inc.
$24
Incyte Corporation
$22
Stemline Therapeutics Inc.
$17
GENZYME CORPORATION
$14
Regeneron Healthcare Solutions, Inc.
$14
Sumitomo Pharma America, Inc.
$14
Top 3 companies account for 76.4% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Biotech, Inc.
$346,015
E.R. Squibb & Sons, L.L.C.
$199,452
Amgen Inc.
$182,315
AstraZeneca Pharmaceuticals LP
$93,956
Merck Sharp & Dohme LLC
$45,858
EMD Serono, Inc.
$44,633
GENZYME CORPORATION
$26,098
PFIZER INC.
$23,172
Fresenius Kabi USA, LLC
$17,221
JAZZ PHARMACEUTICALS INC.
$11,131
Janssen Scientific Affairs, LLC
$10,771
Merck Sharp & Dohme Corporation
$10,456
Lilly USA, LLC
$6,786
Seattle Genetics, Inc.
$5,125
Novartis Pharmaceuticals Corporation
$4,019
Seagen Inc.
$3,255
Eisai Inc.
$2,970
ABBVIE INC.
$2,469
Exelixis Inc.
$2,450
Takeda Pharmaceuticals U.S.A., Inc.
$2,345
Regeneron Healthcare Solutions, Inc.
$2,306
Celgene Corporation
$1,938
Jazz Pharmaceuticals Inc.
$1,662
Bayer Healthcare Pharmaceuticals Inc.
$1,575
Aveo Pharmaceuticals, Inc.
$1,480
Gilead Sciences, Inc.
$1,356
Daiichi Sankyo Inc.
$1,311
Ethicon Inc.
$938
NOVARTIS PHARMACEUTICALS CORPORATION
$675
Astellas Pharma US Inc
$154
Genentech USA, Inc.
$150
BIOPROTECT MEDICAL, INC.
$117
Myovant Sciences Inc.
$95
Kite Pharma, Inc.
$88
Cumberland Pharmaceuticals, Inc.
$64
PROGENICS PHARMACEUTICALS, INC.
$63
Incyte Corporation
$35
Bayer HealthCare Pharmaceuticals Inc.
$34
G1 Therapeutics, Inc.
$29
Dendreon Pharmaceuticals LLC
$20
Stemline Therapeutics Inc.
$17
Pharmacyclics LLC, An AbbVie Company
$14
Sumitomo Pharma America, Inc.
$14
Blue Earth Diagnostics Limited
$13
Epizyme, Inc.,
$12
Top 3 companies account for 69.0% of all-time payments
Associated products mentioned in payments ›
Alecensa · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · Bavencio · COSELA · Cabometyx · DARZALEX · ELIQUIS · ENJAYMO · EPKINLY · ERLEADA · Enhertu · Erleada · FOTIVDA · FRUZAQLA · IBRANCE · IMBRUVICA · IMDELLTRA (AMG 757) · IMFINZI · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kabiven · LIBTAYO · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MONJUVI · Monarch Platform · Neulasta · Nubeqa · OPDIVO · ORGOVYX · Orserdu · PADCEV · PLUVICTO · PROVENGE · PYLARIFY · Padcev · REBLOZYL · RYBREVANT · SANCUSO · SCEMBLIX · Sodium Chloride · Stimufend · TABRECTA · TAGRISSO · TAZVERIK · TECENTRIQ · TEPMETKO · TUKYSA · Tepmetko · Tepotinib · Trodelvy · VENCLEXTA · VERZENIO · Vitrakvi · Vyloy · XTANDI · Xofigo · Xtandi · Yescarta · ZEPZELCA · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for hematology & oncology in OH.

Looking for a hematology & oncology specialist in Cincinnati?
Compare hematology & oncology specialists in the Cincinnati area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
69
Per 100K population
8.3
County median income
$70,816
Nearest hospital
MERCY HEALTH - WEST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Waterhouse is a clinical cardiology specialist, with above-average Medicare volume (top 27% in OH), with speaking/promotional industry engagement in the top 1% of OH peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Waterhouse experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Waterhouse performed 374 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Waterhouse receive payments from pharmaceutical companies?
Yes. Dr. Waterhouse received a total of $1,054,656 from 45 companies across 976 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Waterhouse's costs compare to other hematology & oncology specialists in Cincinnati?
Dr. Waterhouse's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Waterhouse) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →